Rating History for NovaBay Pharmaceuticals (NBY) by Laidlaw
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/29/2019 | Francois Brisebois | Maintain | Hold (N/A) |
1.00 (0.75) |
|
Details | |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/29/2019 | Francois Brisebois | Maintain | Hold (N/A) |
1.00 (0.75) |
|
Details | |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||